UPDATE 1-U.S. FDA approves Parkinson's treatment from Sunovion Pharma
May 21, 2020 at 18:30 PM EDT
The U.S. Food and Drug Administration on Thursday approved a sublingual film from Sunovion Pharmaceuticals Inc, a unit of Japan-based Sumitomo Dainippon Pharma, for the treatment of "off" episodes in patients with Parkinson's disease, the company said.
